Christina Scheffler

PhD student investigating what determines success & failure of adoptive T cell therapy against cancer @TheDohertyInst @unimelb

[Christina Scheffler @ChScheffler]

Great review and must read for anyone working on adoptive T cell therapy!

[Junyun Lai @JunyunLai]

Very excited to share our latest review discussing T cell persistence in adoptive cell therapies in @NatRevImmunol! Huge effort from our brilliant @jack_chan15 & team @paulbeavis4 @slaney_clare Phil Darcy & Axel Kallies @PeterMacRes

https://t.co/xF4YFeAL5S

[Bridget Rollason @bridgerollo]

This is what the new Australian Institute of Infectious Disease will look like, in Melbourne Expected to be completed by 2025. @abcmelbourne

[Nature Immunology @NatImmunol]

T cell exhaustion limits antitumor immune responses. Vignali and colleagues identify neuropilin-1 as a novel immune checkpoint that cell-intrinsically operates to limit memory cell formation and can be targeted to enhance antitumor responses.https://t.co/bjpYo0y0Um

[Christina Scheffler @ChScheffler]

Abstract submission ends today!

[Christina Scheffler @ChScheffler]

Looking forward to #AVID2020

[Mimotopes @Mimotopes]

Join the virtual exhibition space at #AVID2020 to ask Mimotopes’ representatives all your burning questions directly!

The meeting runs 9th - 10th November. https://t.co/MoYyGzZe29
#OzChem

[Mimotopes @Mimotopes]

Join the virtual exhibition space at #AVID2020 to ask Mimotopes’ representatives all your burning questions directly!

The meeting runs 9th - 10th November. https://t.co/MoYyGzZe29
#OzChem